Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a revolutionary treatment strategy for human cancer patients. However, as the response rate to ICI therapy varies widely among different types of tumours, we are beginning to gain insight into the mechanisms as well as bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Enkui, Ding, Chengsheng, Li, Shuchun, Zhou, Xueliang, Aikemu, Batuer, Fan, Xiaodong, Sun, Jing, Zheng, Minhua, Yang, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997025/
https://www.ncbi.nlm.nih.gov/pubmed/36890557
http://dx.doi.org/10.1186/s40364-023-00460-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997025/
https://www.ncbi.nlm.nih.gov/pubmed/36890557
http://dx.doi.org/10.1186/s40364-023-00460-1

Ejemplares similares